Oracle
ORCL
Amazon
AMZN
Apple
AAPL
Alphabet-A
GOOGL
Meta Platforms
META
US Stock MarketDetailed Quotes
WSFS WSFS Financial
- 53.130
- -0.090-0.17%
Trading Dec 19 13:25 ET
3.13BMarket Cap12.10P/E (TTM)
55.370High52.830Low118.57KVolume54.150Open53.220Pre Close6.35MTurnover0.20%Turnover Ratio12.08P/E (Static)58.90MShares62.75052wk High1.17P/B3.09BFloat Cap39.83752wk Low0.60Dividend TTM58.15MShs Float62.750Historical High1.13%Div YieldTTM4.77%Amplitude2.599Historical Low53.535Avg Price1Lot Size
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
WSFS Financial Stock Forum
$Texas Roadhouse (TXRH.US)$ initiated at equal-weight by Wells Fargo, announced targe price at $113.00.
$Moderna (MRNA.US)$ was upgraded by UBS from neutral to buy, but decreased target price from $221.00 to $191.00.
$Sotera Health Company (SHC.US)$ was upgraded by Keybanc from neutral to buy, announced target price at $24.00.
$Alphabet-C (GOOG.US)$ was downg...
• $Advanced Micro Devices (AMD.US)$ : Raymond James Upgrades to Strong Buy from Outperform - PT $160
• $AutoNation (AN.US)$ : Truist Securities Upgrades to Buy from Hold - PT $140 (from $130)
• $BioLife Solutions (BLFS.US)$ : Oppenheimer Upgrades to Outperform from Perform - PT $28
• $Biomarin Pharmaceutical (BMRN.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $113 (from $96)
• $GoDaddy (GDDY.US)$ : Piper Sandler Upgrades to Overweight ...
No comment yet